Core Viewpoint - The upcoming release of the "National Food Safety Standard for Good Manufacturing Practices for Health Foods" aims to enhance industry regulation and safety standards, following a five-year special rectification action that has significantly improved compliance and reduced non-conformity rates in the health food sector [1][3]. Group 1: Regulatory Actions and Achievements - The State Administration for Market Regulation (SAMR) has conducted a five-year special rectification action, resulting in a continuous non-conformity rate of less than 0.6% in health food inspections over the past five years [1]. - A total of 31,000 cases have been investigated, with fines amounting to 540 million yuan, effectively curbing industry malpractices [1]. - The rectification action has established a comprehensive regulatory system covering pre-approval, production, and post-market surveillance [1]. Group 2: Registration and Filing System - China implements a dual-track system of registration and filing for health foods, which has positively impacted industry development [2]. - Strict registration management is applied to products using complex raw materials, while simpler products like vitamins and minerals are subject to filing management [2]. - The national health food filing regulatory platform has achieved intelligent review capabilities, significantly shortening product market entry times [2]. Group 3: New Standards and Industry Development - The forthcoming standards will enhance source control and set higher requirements for raw material and production process management [3]. - Companies are required to establish a comprehensive food safety management responsibility system and improve management levels [3]. - The revised standards will provide clearer enforcement guidelines and promote a full-chain risk control approach to ensure consumer safety [3].

| 单位：万元 | | --- | | 项目 | 2025年上半年 | | | --- | --- | --- | | | 金额 | 比例 | | 大豆分离蛋白 | 25,087.69 | 32.56% | | 非转基因大豆油 | 16,088.05 | 20.88% | | 组织化蛋白 | 13,436.16 | 17.44% | | 大豆浓缩蛋白 | 15,458.36 | 20.06% | | 其他产品 | 6,985.49 | 9.07% | | 合计 | 77,055.75 | 100.00% | 证券代码：603231 证券简称：索宝蛋白 公告编号：2025-022 宁波索宝蛋白科技股份有限公司 2025年半年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据《上海证券交易所上市公司自律监管指引第 3 号行业信息披露：第十四 号——食品制造》的相关要求，宁波索宝蛋白科技股份有限公司（以下简称"公 司"）现将 2025 年半年度主要经营数据公告如下： 一、按产品类别分类的主营业务销售情况 单位： ...

Core Insights - The health meat product industry chain in Linyi's Lanshan District achieved a total output value of 17.268 billion yuan from January to July this year, with 22 enterprises above designated size cultivated in the industry chain [1] - The district has developed a green "ecological chain" through full-chain integration and innovation, extending beyond the main chain to include resource recycling [1][5] - The region has become a core area for the entire pig industry chain in southern Shandong, with close cooperation among farms, slaughter lines, deep processing workshops, and cold chain distribution [1] Industry Development - The largest automated single slaughterhouse in the country has an annual slaughter capacity of nearly 5 million pigs, with a maximum daily capacity of 30,000 pigs [2] - The quality control process at Jinluo Group involves over 20 inspection procedures throughout the slaughtering process, ensuring the safety of the pork supply [2] - The local industry is focusing on a full industry chain that includes deep processing and cold chain transportation, responding to the increasing consumer demand for "healthy" products [2][3] Market Trends - Consumer demand for meat products has shifted from "basic needs" to "quality-oriented," with low-salt, low-fat, and high-protein products becoming mainstream [3] - Qihui Group's sales of its grilled sausages reached 10 billion units, dominating the market amid competition in the 30 billion yuan sausage market [3] - The company has developed over 500 SKUs of products, utilizing advanced technologies to ensure product quality and safety [3] Sustainability and Innovation - The region's waste utilization rate exceeds 90%, addressing pollution issues while developing new products and business models [7] - Jinluo Group has invested in modern production lines for soybean protein and other products, becoming a significant player in the soybean industry [5][6] - The company has established a dual-circulation ecological agriculture model, processing slaughter waste for reuse and contributing to sustainable practices [6] Strategic Initiatives - A recent meeting focused on the development of the health meat product and biomanufacturing industry chain, emphasizing the importance of leading enterprises in driving growth [8] - The establishment of a specialized task force has led to the development of an action plan and various industry maps to accelerate the construction of the industry chain [8][9] - The region aims to enhance its pig supply chain and reduce reliance on external sources, promoting the expansion of local breeding enterprises [9] Future Outlook - Lanshan District is positioning itself as a national benchmark for the health meat product industry, with a commitment to health, efficiency, and responsibility [10]

证券代码：603231 证券简称：索宝蛋白 公告编号：2025-014 宁波索宝蛋白科技股份有限公司 2025年第一季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 | 项目 | 2025年第一季度 | | | --- | --- | --- | | | 金额 | 比例 | | 境内 | 23,532.92 | 60.24% | | 境外 | 15,532.06 | 39.76% | | 合计 | 39,064.98 | 100.00% | 根据《上海证券交易所上市公司自律监管指引第 3 号行业信息披露：第十四 号——食品制造》的相关要求，宁波索宝蛋白科技股份有限公司（以下简称"公 司"）现将 2025年第一季度主要经营数据公告如下： 一、按产品类别分类的主营业务销售情况 单位：万元 | 项目 | 2025年第一季度 | | | --- | --- | --- | | | 金额 | 比例 | | 大豆分离蛋白 | 12,475.93 | 31.94% | | 非转基因大豆油 | 8,727.65 | 22. ...

宁波索宝蛋白科技股份有限公司 Solbar Ningbo Protein Technology Co., Ltd. (注册地址:浙江省宁波保税区兴业大道12号) 首次公开发? 在主板上市 招股说明书 (注册稿) 本公司的发行申请尚需经上海证券交易所和中国证监会履行相应程序。本招 股说明书不具有据以发行股票的法律效力,仅供预先披露之用。投资者应当 以正式公告的招股说明书全文作为作出投资决定的依据。 保荐机构(主承销商) FILE HOST SOOCHOW SECURITIES CO.,LTD (注册地址:苏州工业园区星阳街5号) 发行人声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发行 人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行承担 股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-1 宁波索宝 ...

宁波索宝蛋白科技股份有限公司 （注册地址：浙江省宁波保税区兴业大道 12 号） 首次公开发行股票并在主板上市 招股说明书 （上会稿） 本公司的发行申请尚需经上海证券交易所和中国证监会履行相应程序。本招 股说明书不具有据以发行股票的法律效力，仅供预先披露之用。投资者应当 保荐机构（主承销商） 1-1-1 Solbar Ningbo Protein Technology Co., Ltd. 以正式公告的招股说明书全文作为作出投资决定的依据。 1-1-1 宁波索宝蛋白科技股份有限公司 招股说明书（上会稿） 本次发行概况 （注册地址：苏州工业园区星阳街5号） | 股票种类 | 人民币普通股（A 股） | | --- | --- | | 发行股数 | 本次公开发行股票数量不超过 万股，全部为新股发行，不涉 4,786.48 | | | 及股东公开发售股份。 | | 每股面值 | 人民币 1.00 元 | | 每股发行价格 | 人民币【】元 | | 预计发行日期 | 【】年【】月【】日 | | 拟上市的证券交易 所 | 上海证券交易所 | | 发行后总股本 | 不超过 19,145.9105 万股 | | 保荐人、主承销 ...

宁波索宝蛋白科技股份有限公司 Solbar Ningbo Protein Technology Co., Ltd. （注册地址：浙江省宁波保税区兴业大道 12 号） 首次公开发行股票并在主板上市 招股说明书 （申报稿） 本公司的发行申请尚需经上海证券交易所和中国证监会履行相应程序。本招 股说明书不具有据以发行股票的法律效力，仅供预先披露之用。投资者应当 以正式公告的招股说明书全文作为作出投资决定的依据。 保荐机构（主承销商） （注册地址：苏州工业园区星阳街5号） 1-1-1 发行人声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发行 人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行承担 股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-1 宁波索宝蛋白科技股份有限公司 招股说明书（申报稿） 本次发行概 ...

宁波索宝蛋白科技股份有限公司 Solbar Ningbo Protein Technology Co., Ltd. （注册地址：浙江省宁波保税区兴业大道 12 号） 首次公开发行股票 招股说明书 （申报稿） 保荐机构（主承销商） （注册地址：苏州工业园区星阳街5号） 宁波索宝蛋白科技股份有限公司 招股说明书（申报稿） 声明：本公司的发行申请尚未得到中国证监会核准。本招股说明书（申报稿） 不具有据以发行股票的法律效力，仅供预先披露之用。投资者应当以正式公告的 招股说明书全文作为作出投资决定的依据。 | 股票种类 | 股） 人民币普通股（A | | --- | --- | | 发行股数 | 本次公开发行股票数量不超过 4,786.48 万股，全部为新股发行，不涉 | | | 及股东公开发售股份。 | | 每股面值 | 人民币 元 1.00 | | 每股发行价格 | 人民币【】元 | | 预计发行日期 | 【】年【】月【】日 | | 拟上市的证券交易 | 上海证券交易所 | | 所 | | | 发行后总股本 | 不超过 万股 19,145.91 | | 本次发行前股东所 持股份的流通限制、 | 参见本招股说明书"重 ...